Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8754073 Substituted piperazino-dihydrothienopyrimidines

Patent 8754073 was granted and assigned to Boehringer Ingelheim on June, 2014 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Boehringer Ingelheim

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

87540730

Patent Inventor Names

Thomas Fox0

Christoph Hoenke0

Dennis Fiegen0

Domnic Martyres0

Horst Dollinger0

Klaus Klinder0

Pascale Pouzet0

Peter Nickolaus0

...

Date of Patent

June 17, 2014

Patent Application Number

127383440

Date Filed

October 16, 2008

Patent Citations Received

‌

US Patent 11981681 Substituted azetidine dihydrothienopyridines and their use as phosphodiesterase inhibitors

‌

US Patent 11866445 Substituted dihydrothienopyrimidines and their use as phosphodiesterase inhibitors

Patent Primary Examiner

‌

Susanna Moore

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8754073 Substituted piperazino-dihydrothienopyrimidines

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API